Search

Your search keyword '"Cox, Jafna"' showing total 497 results

Search Constraints

Start Over You searched for: Author "Cox, Jafna" Remove constraint Author: "Cox, Jafna"
497 results on '"Cox, Jafna"'

Search Results

5. Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

6. Assay precision and risk of misclassification at rule-out cut-offs for high-sensitivity cardiac troponin

7. Colchicine for Prevention of Atherothrombotic Events in Patients With Coronary Artery Disease: Review and Practical Approach for Clinicians

9. The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation

10. Imprecision of high-sensitivity cardiac troponin assays at the female 99th-percentile

12. Association Between Patient and Physician Sex and Physician-Estimated Stroke and Bleeding Risks in Atrial Fibrillation

13. Recommandations canadiennes pour les pratiques optimales de soins de l'AVC, septieme edition : l'acide acetylsalicylique pour la prevention d'evenements vasculaires

14. Canadian Stroke Best Practice Recommendations, seventh edition: acetylsalicylic acid for prevention of vascular events

15. 2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation

17. Use of Evidence-Based Therapy for Cardiovascular Risk Factors in Canadian Outpatients With Atrial Fibrillation: From the Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation (FREEDOM AF) and Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation (CONNECT AF)

20. Analytic result variation for high-sensitivity cardiac troponin: Interpretation and consequences

21. 2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation

24. The 2014 Atrial Fibrillation Guidelines Companion: A Practical Approach to the Use of the Canadian Cardiovascular Society Guidelines

27. Canadian Stroke Best Practice Recommendations: Secondary Prevention of Stroke Update 2020 – ADDENDUM

28. Rhythm Control Vs Rate Control in a Contemporary Ambulatory Atrial Fibrillation Cohort: Post Hoc Analysis of the IMPACT-AF Trial

31. Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

32. The association between anticoagulation and adverse outcomes after a positive SARS-CoV-2 test among older outpatients: A population-based cohort study

33. Identification and Management of Cardiometabolic Risk in Canada: A Position Paper by the Cardiometabolic Risk Working Group (Executive Summary)

34. Cardiometabolic Risk in Canada: A Detailed Analysis and Position Paper by the Cardiometabolic Risk Working Group

42. Surveillance for Outcomes Selected as Atrial Fibrillation Quality Indicators in Canada: 10-Year Trends in Stroke, Major Bleeding, and Heart Failure

44. Cardiovascular outcomes after a change in prescription policy for Clopidogrel

48. Trends in event rate and case fatality of patients hospitalized with myocardial infarction between 1984 and 2001 (1)

Catalog

Books, media, physical & digital resources